Cargando…
NEO212: sub-cytotoxic doses capable of inhibiting glioma stem cell invasion
Autores principales: | Marín-Ramos, Nagore I., Hofman, Florence M., Chen, Thomas C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049296/ https://www.ncbi.nlm.nih.gov/pubmed/30035171 http://dx.doi.org/10.18632/oncoscience.429 |
Ejemplares similares
-
Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice
por: Cho, Hee-Yeon, et al.
Publicado: (2020) -
Cytotoxic impact of a perillyl alcohol–temozolomide conjugate,
NEO212, on cutaneous T-cell lymphoma in vitro
por: Silva-Hirschberg, Catalina, et al.
Publicado: (2019) -
NEO212 induces mitochondrial apoptosis and impairs autophagy flux in ovarian cancer
por: Song, Xingguo, et al.
Publicado: (2019) -
NEO212, a Perillyl Alcohol-Temozolomide Conjugate, Triggers Macrophage Differentiation of Acute Myeloid Leukemia Cells and Blocks Their Tumorigenicity
por: Chen, Thomas C., et al.
Publicado: (2022) -
Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways
por: Wang, Kun, et al.
Publicado: (2021)